Translational Medicine in the Diagnosis and Treatment of Cancer based on Oncogenetics: From Bench to Bedside

Translational Medicine in the Diagnosis and Treatment of Cancer based on Oncogenetics: From Bench to Bedside
Author :
Publisher : Frontiers Media SA
Total Pages : 207
Release :
ISBN-10 : 9782832540121
ISBN-13 : 2832540120
Rating : 4/5 (120 Downloads)

Book Synopsis Translational Medicine in the Diagnosis and Treatment of Cancer based on Oncogenetics: From Bench to Bedside by : Changjing Cai

Download or read book Translational Medicine in the Diagnosis and Treatment of Cancer based on Oncogenetics: From Bench to Bedside written by Changjing Cai and published by Frontiers Media SA. This book was released on 2023-12-07 with total page 207 pages. Available in PDF, EPUB and Kindle. Book excerpt: Translational medicine was first mentioned in 1992 by Choi D. W and has since become a rapidly expanding area within biomedical research. It is based on the ‘bench to bedside’ approach, which describes it’s relationship between basic science and clinical practice. In 2008, Drs Conway and Dougherty provided a 3 step process to translational medicine and how it should be implemented to transform healthcare systems. The first step is the translation of basic science into clinical research (T1). The second step (T2) focuses on making healthcare more patient specific, basing itself on providing ‘the right treatment for the right patient in the right way at the right time’. T2 also looks for this science to be translated into practice guidelines for clinicians, policy makers and the patients themselves. The final step (T3) addresses the ‘how’ of implementing these ideas, so that high quality healthcare can be delivered reliably to all patients in all settings of care. T3 activities would include policy changes that could serve to bring about meaningful change towards this goal. Cancer is a major public health problem worldwide. Clarifying the etiology and pathogenesis of cancer is of great significance to the prevention, diagnosis, and treatment of the disease. The bench to bedside pattern can be a useful method for cancer-related studies. This Research Topic aims to highlight the emerging role of oncogenetics in cancer, and discuss potential challenges of diagnosis and treatment, from the bench to the bedside.


Translational Medicine in the Diagnosis and Treatment of Cancer based on Oncogenetics: From Bench to Bedside Related Books

Translational Medicine in the Diagnosis and Treatment of Cancer based on Oncogenetics: From Bench to Bedside
Language: en
Pages: 207
Authors: Changjing Cai
Categories: Medical
Type: BOOK - Published: 2023-12-07 - Publisher: Frontiers Media SA

DOWNLOAD EBOOK

Translational medicine was first mentioned in 1992 by Choi D. W and has since become a rapidly expanding area within biomedical research. It is based on the ‘
Translational Research in Breast Cancer
Language: en
Pages: 418
Authors: Erwei Song
Categories: Medical
Type: BOOK - Published: 2017-12-28 - Publisher: Springer

DOWNLOAD EBOOK

This book offers a comprehensive introduction to translational efforts in breast cancer, addressing the latest approaches to precision medicine based on the cur
Genomic Medicine
Language: en
Pages: 853
Authors: Dhavendra Kumar
Categories: Medical
Type: BOOK - Published: 2014-10-15 - Publisher: Oxford Monographs on Medical G

DOWNLOAD EBOOK

Preceded by Genomics and clinical medicine / edited by Dhavendra Kumar. [First edition]. 2008.
Principles of Translational Science in Medicine
Language: en
Pages: 495
Authors: Martin Wehling
Categories: Science
Type: BOOK - Published: 2021-07-15 - Publisher: Academic Press

DOWNLOAD EBOOK

Principles of Translational Science in Medicine: From Bench to Bedside, Third Edition, provides an update on major achievements in the translation of research i
RNA Delivery Function for Anticancer Therapeutics
Language: en
Pages: 860
Authors: Loutfy H. Madkour
Categories: Science
Type: BOOK - Published: 2022-01-26 - Publisher: CRC Press

DOWNLOAD EBOOK

This book presents an overview of the current status of translating the RNAi cancer therapeutics in the clinic, a brief description of the biological barriers i